| Name | Title | Contact Details |
|---|
Garrison Investment Group is a middle market credit, distressed and asset based investor. The firm was founded in 2007 and is headquartered in New York. We are a multi-strategy investment manager that deploys capital in opportunities across Corporate Finance (lending and distressed), Financial Assets (commercial, industrial and consumer loans as well as hard asset lending and structured finance), and Real Estate (equity and debt). Our team of experienced professionals enables us to source and execute defensible transactions across our multiple investing disciplines. Garrison manages investor capital through a diversified set of vehicles including private equity format funds and corporate credit lending funds as well as separately managed accounts. In addition, we manage collateralized loan obligations (CLOs) through our affiliate, Garrison Loan Management, and a business development company, Garrison Capital Inc.
The Alberta Investment Management Corporation (AIMCo) is a Crown corporation, owned by the Province of Alberta, and one of Canada`s largest and most diversified institutional investment managers. AIMCo was established on January 1, 2008 with a mandate to provide superior long-term investment results for its clients and operates independently from the Government of Alberta. With assets under management of more than $150 billion, AIMCo invests globally on behalf of 32 Alberta-based pension, endowment and government funds, including the Alberta Heritage Savings Trust Fund.
Cardinal Investments is a El Segundo, CA-based company in the Financial Services sector.
Equilibra is the family office of Daniel Lubetzky, Founder and Executive chairman of KIND.
NaviMed Capital is a Washington, DC-based private capital firm focused exclusively on the healthcare industry. NaviMed makes substantial investments in fast growing lower middle market healthcare businesses. The firm focus on healthcare services, healthcare IT, hospital products, and distribution businesses which are poised to benefit from the reform and technology innovation forces reshaping the healthcare industry. NaviMed targets profitable private companies with up to $10 million of EBITDA and double digit revenue growth. NaviMed seeks investments which can benefit from its deep industry expertise, broad relationship network and combined 50+ year track record of success as healthcare investors and operators. NaviMed`s senior investment team has a track record of value creation spanning dozens of investments and more than $6.5 billion of enterprise value created.